FLEXIMIND Trademark

Trademark Overview


On Thursday, January 25, 2024, a trademark application was filed for FLEXIMIND with the United States Patent and Trademark Office. The USPTO has given the FLEXIMIND trademark a serial number of 98375001. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, August 27, 2024. This trademark is owned by FlexiMind. The FLEXIMIND trademark is filed in the Pharmaceutical Products category with the following description:

FlexiMind is an all-in-one supplement.
fleximind

General Information


Serial Number98375001
Word MarkFLEXIMIND
Filing DateThursday, January 25, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFlexiMind is an all-in-one supplement.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 25, 2024
Primary Code005
First Use Anywhere DateMonday, December 4, 2023
First Use In Commerce DateMonday, December 4, 2023

Trademark Owner History


Party NameFlexiMind
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEnglewood, CO 80110

Trademark Events


Event DateEvent Description
Thursday, January 25, 2024NEW APPLICATION ENTERED
Monday, July 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 21, 2024ASSIGNED TO EXAMINER
Tuesday, August 27, 2024NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2024NON-FINAL ACTION WRITTEN
Tuesday, August 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


fleximind supplement